Moleculin Biotech, Inc.
Pharmaceutical Preparations · HOUSTON · TX
Moderate confidence (50%)
Updated Oct 20, 2026, 12:03 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: Moleculin Biotech, Inc. received a delisting notice from its exchange (Sep 15, 2026)
Timeline
Every material event, newest first. History is never overwritten.
Moleculin Biotech, Inc. received a delisting notice from its exchange
Sep 15, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On September 15, 2026, Moleculin Biotech, Inc. (the Company ) received a letter (the Staff Determination Letter ) from the Listing Qualifications Department (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that the Staff has determined that the closing bid price of the Company s common stock, par value $0.001 per share (the Common Stock ), has been below $1.00 per share for the previous 30 consecutive business days (from July 31, 2026 through September 11,…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker MBRX on Nasdaq.
- SEC CIK
- 0001659617
- Website
- —
- —
- Headquarters
- HOUSTON, TX
- Also known as
- —
- Legal entities
- Moleculin Biotech, Inc.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
Moleculin Biotech, Inc. — Pharmaceutical Preparations (SIC 2834) — HOUSTON, TX
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On September 15, 2026, Moleculin Biotech, Inc. (the Company ) received a letter (the Staff Determination Letter ) from the Listing Qualifications Department (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that the Staff has determined that the closing bid price of the Company s common stock, par value $0.001 per share (the Common Stock ), has been below $1.00 per share for the previous 30 consecutive business days (from July 31, 2026 through September 11,…
View source record
Status history
Every derived status, with the rule that produced it.
- UNKNOWN → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 20, 2026, 12:14 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.